Promising mouse studies and billions of dollars in funding are stoking excitement. But we’ve been here before.
The approach relies on “reprogramming” cells to a younger state. It’s one of many strategies being explored by biotech ...
A comprehensive review recently published in Current Molecular Pharmacology illuminates the pivotal, multifaceted roles of ...
Scientists have taken a small but significant step toward testing the idea of reverse aging in humans. Researchers have ...
In a breakthrough for longevity science, a reverse-aging treatment has been injected into a human. The technique is a sought-after solution for improving longevity by reprogramming cells. Competitors ...
The first participant has been treated in a landmark clinical trial of cellular reprogramming, which aims to rejuvenate aging ...
Novel immune reprogramming oral macrocyclic peptides designed for precise modulation of complex biological networks involved in inflammatory, ...
A: We already are seeing autonomous behaviors – like real‑time signal classification and threat response – that exceed human ...
A gastrointestinal oncologist told Newsweek that the early-stage findings are a “major step forward” in targeting colon ...
Late-onset Alzheimer’s disease (LOAD) accounts for over 95% of Alzheimer’s disease (AD) cases. However, modeling the age-dependent neuropathological hallmarks of LOAD has remained a major challenge.
The treatment, currently designated HTX-001, is an antisense oligonucleotide, or ASO, that targets Wisper and reduces the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results